|
|
|
Insider
Information: |
Orbimed Capital Gp Vi Llc |
Relationship: |
Director, 10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
17 |
|
Direct
Shares |
5,826,224 |
|
Indirect Shares
|
46,949,846 |
|
|
Direct
Value |
$279,950,063 |
|
|
Indirect Value
|
$488,548,121 |
|
|
Total
Shares |
52,776,070 |
|
|
Total
Value |
$768,498,184 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
14
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
14
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-14.0
|
Percentage
Gain/Loss : |
0.0%
|
-1,246.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Synlogic Inc |
SYBX |
Director |
|
0 |
2021-04-20 |
3,696,662 |
Premium* |
|
Kala Pharmaceuticals, Inc. |
KALA |
10% Owner |
2018-01-12 |
0 |
2018-02-08 |
3,447,840 |
Premium* |
|
Adicet Bio, Inc |
ACET |
Director, 10% Owner |
2018-01-30 |
0 |
2018-01-30 |
4,830,387 |
Premium* |
|
Constellation Pharmaceuticals Inc |
CNST |
10% Owner |
2018-07-23 |
0 |
2018-07-23 |
417,921 |
Premium* |
|
Alpine Immune Sciences Inc |
ALPN |
Director, 10% Owner |
2019-01-18 |
0 |
2020-12-28 |
3,070,955 |
Premium* |
|
Turning Point Therapeutics, Inc. |
TPTX |
Director |
2019-04-22 |
0 |
2019-04-22 |
2,027,550 |
Premium* |
|
Nextcure, Inc. |
NXTC |
Director, 10% Owner |
2019-05-13 |
0 |
2019-05-13 |
2,711,013 |
Premium* |
|
Prevail Therapeutics Inc. |
PRVL |
Director, 10% Owner |
|
0 |
2021-01-22 |
0 |
Premium* |
|
Springworks Therapeutics, Inc. |
SWTX |
10% Owner |
2019-09-17 |
0 |
2022-09-12 |
5,599,842 |
Premium* |
|
Cti Biopharma Corporation |
CTIC |
10% Owner |
|
0 |
2021-01-07 |
7,520,600 |
Premium* |
|
Oric Pharmaceuticals, Inc. |
ORIC |
Director |
2020-04-24 |
0 |
2021-03-30 |
2,212,571 |
Premium* |
|
Prelude Therapeutics Inc |
PRLD |
Director, 10% Owner |
|
0 |
2020-09-24 |
206,912 |
Premium* |
|
Calcimedica Ord Shs |
CALC |
10% Owner |
2020-09-25 |
0 |
2020-09-29 |
4,163,347 |
Premium* |
|
Silverback Therapeutics, Inc. |
SBTX |
Director, 10% Owner |
|
0 |
2020-12-03 |
538,646 |
Premium* |
|
Disc Medicine, Inc |
IRON |
Director, 10% Owner |
2021-02-05 |
5,826,224 |
|
0 |
Premium* |
|
Neuropace Inc |
NPCE |
10% Owner |
2021-04-21 |
0 |
2024-05-03 |
3,406,335 |
Premium* |
|
Turnstone Biologics Corp. |
TSBX |
Director, 10% Owner |
2023-07-20 |
0 |
2023-07-20 |
3,099,265 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
84 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SYBX |
Synlogic Inc |
Director |
|
2017-08-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,314,996 |
|
- |
|
PRVL |
Prevail Therapeutics Inc. |
Director |
|
2019-06-19 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,430,000 |
|
- |
|
CTIC |
Cti Biopharma Corporation |
10% Owner |
|
2020-03-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,520,000 |
|
- |
|
PRLD |
Prelude Therapeutics Inc |
Director |
|
2020-09-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
206,912 |
|
- |
|
SBTX |
Silverback Therapeutics, ... |
Director |
|
2020-12-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
538,646 |
|
- |
|
IRON |
Disc Medicine, Inc |
Director |
|
2021-02-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,826,224 |
|
- |
|
ACET |
Adicet Bio, Inc |
Director |
|
2018-01-30 |
4 |
A |
$0.00 |
$0 |
I/I |
4,297,054 |
4,297,054 |
0 |
- |
|
CNST |
Constellation Pharmaceuti... |
10% Owner |
|
2018-07-23 |
4 |
A |
$0.00 |
$0 |
I/I |
635,842 |
317,921 |
0 |
- |
|
TPTX |
Turning Point Therapeutic... |
Director |
|
2019-04-22 |
4 |
A |
$0.00 |
$0 |
I/I |
1,667,550 |
1,667,550 |
0 |
- |
|
NXTC |
Nextcure, Inc. |
Director |
|
2019-05-13 |
4 |
A |
$0.00 |
$0 |
I/I |
2,361,013 |
2,361,013 |
0 |
- |
|
PRVL |
Prevail Therapeutics Inc. |
Director |
|
2019-06-24 |
4 |
A |
$0.00 |
$0 |
I/I |
10,510,111 |
12,940,111 |
0 |
- |
|
SWTX |
Springworks Therapeutics,... |
10% Owner |
|
2019-09-17 |
4 |
A |
$0.00 |
$0 |
I/I |
7,131,307 |
7,131,307 |
0 |
- |
|
ORIC |
Oric Pharmaceuticals, Inc... |
Director |
|
2020-04-28 |
4 |
A |
$0.00 |
$0 |
I/I |
2,484,467 |
2,765,717 |
0 |
- |
|
CALC |
Calcimedica Ord Shs |
10% Owner |
|
2020-09-29 |
4 |
A |
$0.00 |
$0 |
I/I |
3,600,847 |
4,163,347 |
0 |
- |
|
PRVL |
Prevail Therapeutics Inc. |
Director |
|
2021-01-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(13,822,463) |
0 |
0 |
- |
|
NPCE |
Neuropace Inc |
10% Owner |
|
2021-04-26 |
4 |
A |
$0.00 |
$0 |
I/I |
3,777,281 |
4,012,281 |
0 |
- |
|
TSBX |
Turnstone Biologics Corp. |
Director |
|
2023-07-20 |
4 |
A |
$0.00 |
$0 |
I/I |
2,682,599 |
2,682,599 |
0 |
- |
|
NPCE |
Neuropace Inc |
10% Owner |
|
2024-04-17 |
4 |
S |
$14.15 |
$4,245 |
I/I |
(300) |
3,504,598 |
0 |
% |
|
NPCE |
Neuropace Inc |
10% Owner |
|
2023-10-03 |
4 |
S |
$9.02 |
$6,314 |
I/I |
(700) |
4,003,967 |
0 |
% |
|
SWTX |
Springworks Therapeutics,... |
10% Owner |
|
2021-06-23 |
4 |
AS |
$85.00 |
$8,500 |
I/I |
(100) |
6,107,302 |
0 |
- |
|
NPCE |
Neuropace Inc |
10% Owner |
|
2024-04-24 |
4 |
S |
$14.06 |
$25,041 |
I/I |
(1,781) |
3,435,541 |
0 |
% |
|
SWTX |
Springworks Therapeutics,... |
10% Owner |
|
2021-06-07 |
4 |
AS |
$84.90 |
$31,498 |
I/I |
(371) |
6,185,936 |
0 |
- |
|
NPCE |
Neuropace Inc |
10% Owner |
|
2024-04-18 |
4 |
S |
$14.06 |
$36,879 |
I/I |
(2,623) |
3,501,975 |
0 |
% |
|
KALA |
Kala Pharmaceuticals, Inc... |
10% Owner |
|
2018-01-23 |
4 |
B |
$14.99 |
$65,401 |
I/I |
4,363 |
2,885,363 |
1.5 |
- |
|
NPCE |
Neuropace Inc |
10% Owner |
|
2024-05-03 |
4 |
S |
$14.03 |
$65,576 |
I/I |
(4,674) |
3,406,335 |
0 |
% |
|
84 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|